Crinetics Pharmaceuticals CRNX Increase (decrease) in contract liabilities and current deferred income

Increase (decrease) in contract liabilities and current deferred income at other companies

SPS CommerceSPSC

$4.87M+54.2%

AvePoint, Inc.AVPT

$4.39M+4.3%

Q2 HoldingsQTWO

$45.49M+26.0%

AMN HealthcareAMN

-$4.41M-312%

CalixCALX

$675K-80.6%

Rackspace Technology, Inc.RXT

$35.6M+483%

Other financials

Income statement

See full

Revenue$10.7M+2,873%

Gross profit$10.5M+2,818%

Operating income-$140.4M-26.0%

Net income-$127.8M-32.1%

EPS (diluted)-$1.23-18.3%

Balance sheet

See full

Cash & equivalents$115.1M+20.1%

Total debt$47.9M-5.8%

Total equity$1.3B+2.1%

Total assets$1.4B+2.9%

Cash flow

See full

Operating cash flow-$124.7M-41.0%

CapEx$820.0K-33.8%

Free cash flow-$125.5M-40.0%

Valuation

See full

Market cap$3.81B+21.9%

Enterprise value$3.75B+21.5%

P/S211.1×-3,908×

Profitability

See full

Gross margin150%-15.6pp

Operating margin-3,020.3%-1,463pp

Net margin-2,747.2%-1,328pp

FCF margin-2,321.7%-1,122pp

Returns & leverage

See full

Return on equity-39.2%+14.5pp

Debt / equity0×0.0×

Current ratio18.6×-3.9×

Where this comes from

Reported directly by Crinetics Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInContractWithCustomerLiability.

The official record: Crinetics Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Crinetics Pharmaceuticals's increase (decrease) in contract liabilities and current deferred income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Crinetics Pharmaceuticals's increase (decrease) in contract liabilities and current deferred income?: Crinetics Pharmaceuticals (CRNX) reported increase (decrease) in contract liabilities and current deferred income of -$428K in Q1 2026.
How has Crinetics Pharmaceuticals's increase (decrease) in contract liabilities and current deferred income changed year-over-year?: Crinetics Pharmaceuticals's increase (decrease) in contract liabilities and current deferred income decreased by 18.6% year-over-year, from -$361K to -$428K.